On September 29, 2022, the European Commission issued draft Implementing Decision that does not approve 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an active substance for use in biocidal products of product-type 4.
what our clients say
VP of Compliance
US based, Leading Consumer Products Company
Freyr’s support was unbelievably helpful and quite comprehensive.
A Leader in Skin Health
Cosmetics Regulatory Services
Thank you very much for working with us on the India Cosmetic project. We appreciate your resource’s diligence and focus and attention to detail. Very lucky of you to have them in your team.
Global Regulatory Affairs,
A World-wide Leader in Health and Beauty
Outstanding Freyr Team! You guys rocked!
Thank you for the awesome work that you guys have provided for both the projects Cosmetics and RI that both met the cost and project deliverables. We are extremely satisfied with the outstanding technical leadership, and the output that met our expectations.
Looking forward to partner with you for future projects.
Regulatory Affairs Specialist
A pioneer in natural luxury skincare
Thank you so much for all that you have done and continue to do for us; we really appreciate it. Kudos to all Freyr’s efforts. Thank you, all the team, so very much for getting all our products approved successfully. We are all doing a happy dance!!!
Manager - New Country Development
One of the India's leading consumer goods companies
Really appreciate the quick turn-around time and the efforts that the team has put in to send the artworks on time. Kudos!